Current opinion in ophthalmology
-
Curr Opin Ophthalmol · Sep 2020
ReviewOphthalmology conferences in the coronavirus disease 2019 era.
To discuss key considerations involved in adapting an in-person ophthalmology conference to a virtual medium. ⋯ Transition of an in-person ophthalmology conference to a virtual format with retention of the inherent value associated with the meeting is possible and the experiences of societies executing this adaptation can be helpful for others entering this space. There are numerous considerations regarding meeting format and logistics to contemplate in light of each meeting's specific audience and objectives.
-
Curr Opin Ophthalmol · Sep 2020
ReviewIncorporating a virtual curriculum into ophthalmology education in the coronavirus disease-2019 era.
The purpose of this review is to describe the transition of ophthalmology education to a virtual curriculum during the COVID-19 pandemic. We highlight innovative solutions ophthalmic educators implemented for medical students, residents, and fellows. ⋯ The COVID-19 pandemic transformed ophthalmology education overnight and accelerated the adoption of innovative e-virtual learning resources for trainees. These changes will undoubtedly remain part of the new paradigm of medical education in the post-COVID era.
-
To summarize how big data and artificial intelligence technologies have evolved, their current state, and next steps to enable future generations of artificial intelligence for ophthalmology. ⋯ Future requirements for big data and artificial intelligence include fostering reproducible science, continuing open innovation, and supporting the clinical use of artificial intelligence by promoting standards for data labels, data sharing, artificial intelligence model architecture sharing, and accessible code and APIs.
-
Curr Opin Ophthalmol · Sep 2020
ReviewOphthalmic manifestations of coronavirus disease 2019 and ocular side effects of investigational pharmacologic agents.
To compile and report the ocular manifestations of coronavirus disease 2019 (COVID-19) infection and summarize the ocular side effects of investigational treatments of this disease. ⋯ Eye care professionals must exercise caution, as conjunctivitis may be the presenting or sole finding of an active COVID-19 infection. While no currently studied therapeutic agents have been found to reliably treat COVID-19, early vaccination trials are progressing and show promise. A video abstract is available for a more detailed summary. VIDEO ABSTRACT: http://links.lww.com/COOP/A36.
-
Curr Opin Ophthalmol · Sep 2020
Comparative StudyOcular trauma during COVID-19 stay-at-home orders: a comparative cohort study.
The aim of this study was to report characteristics of patients presenting with serious ocular injuries during the COVID-19 stay-at-home orders. ⋯ During the COVID-19 pandemic, patients with ocular trauma were more likely to have injuries sustained at home and have additional barriers to care. These changes underscore a need for targeted interventions to optimize emergent eye care during a pandemic.